NCT02512159

Brief Summary

The aim of this study was to evaluate the efficacy of a handicraft topical device of negative pressure versus traditional healing treatment for skin ulcers in lower limbs; in patients with diabetes mellitus, venous stasis and arterial insufficiency.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2014

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2015

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 30, 2015

Completed
Last Updated

July 30, 2015

Status Verified

February 1, 2014

Enrollment Period

7 months

First QC Date

March 12, 2015

Last Update Submit

July 29, 2015

Conditions

Keywords

Diabetic foot ulcerFoot careWound management

Outcome Measures

Primary Outcomes (1)

  • Presence of granulation tissue in skin ulcers.

    Presence of granulation tissue in 50% of the wound

    10 days

Secondary Outcomes (4)

  • Leukocyte less than 11,000 mm3.

    10 days

  • Temperature

    10 days

  • Breathing Rate

    10 days

  • Heart Rate

    10 days

Study Arms (2)

drenovac handcrafted

EXPERIMENTAL

Patients treatment with the handicraft topical device negative pressure therapy Economic craft

Procedure: drenovac handcrafted

Healing

ACTIVE COMPARATOR

Patients who were managed with traditional "conservative treatment".

Procedure: Healing

Interventions

under local anesthesia, sepsis and antisepsis, place sterile field, prepared area go out all devitalized or necrotic tissue using liquid soap surgical and irrigation back saline 0.9%. We introduce a device to distribute the negative pressure or vacuum on ulcer; conducted margins make recommendations 5-12 mm over the edge of the wound, applying negative pressure or vacuum retracted sponges, likewise for the spare fewer gauze was placed Sterile adhesive film covering the defect to seal the system cover adequately the probe output nelaton not to submit drain the system. Connect the probe to the sterile nelaton this hose and a suction system with pressure gauge, pressure -80-125 mmHg. Change it every 72 hours.

drenovac handcrafted
HealingPROCEDURE

Were handled as follows: 1. Under local anesthesia, prior asepsis and antisepsis of the skin ulcer with iodinepovidone sterile fields are placed, we proceeded to debridement of all necrotic tissue or devitalized then a cure with liquid soap surgery was performed and was irrigated with 1000 cc of solution physiological 0.9%, and finally the ulcer was covered with sterile gauze. 2. healing of skin ulcers were performed every 24 hours. 3. the evolution of skin ulcers was evaluated every 3 days, requesting a differential valuing of clinical and biochemical form the aforementioned variables.

Healing

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with cutaneous leg ulcers due to diabetes mellitus, venous stasis and arterial insufficiency requiring healing or tissue debrided sent to managing their disease to regional general hospital No. 17, Instituto Mexicano del Seguro Social, Benito Juárez, Quintana Roo.
  • Patients of both sexes.
  • Patients over 18 years.
  • Patients that have basic laboratory at admission (complete blood count with differential).
  • Patients with comorbidities associated as Diabetes Mellitus , Hypertension, stroke, heart disease, nephropathy, venous insufficiency and arterial insufficiency, etc.

You may not qualify if:

  • Hemodynamically unstable patients.
  • Patients with septic shock from any source.
  • Patients with deep skin ulcers with exposed some organ, data osteomyelitis, vascular-nervous exposure.
  • Patients with secondary cutaneous ulcer enteral fistula.
  • Patients with cutaneous ulcer or cancer tumors.
  • Patients with cutaneous ulcer with active bleeding.
  • Patients with cutaneous ulcer necrosis.
  • Patients with cutaneous ulcer leishmania, insect bite.
  • Patients with cutaneous ulcer burns.
  • Patients who do not accept their participation in the study through informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Gonzalez IG, Angel MA, Baez MV, Ruiz Flores B, de Los Angeles Martinez Ferretiz M, Woolf SV, Lopez I, Sandoval-Jurado L, Pat-Espadas FG, Cruz AA, Delgado AT. Handcrafted Vacuum-Assisted Device for Skin Ulcers Treatment Versus Traditional Therapy, Randomized Controlled Trial. World J Surg. 2017 Feb;41(2):386-393. doi: 10.1007/s00268-016-3782-9.

MeSH Terms

Conditions

Foot UlcerVaricose UlcerDiabetic Foot

Condition Hierarchy (Ancestors)

Foot DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLeg UlcerSkin UlcerVaricose VeinsVascular DiseasesCardiovascular DiseasesDiabetic AngiopathiesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Officials

  • Fany Guadalupe Pat Espadas, MCs

    IMSS

    PRINCIPAL INVESTIGATOR
  • Israel Augusto González González, Dr.

    IMSS

    STUDY CHAIR
  • Luis Sandoval Jurado, PhD

    IMSS

    STUDY DIRECTOR
  • Ma. Valeria Jiménez Baéz, PhD

    IMSS

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2015

First Posted

July 30, 2015

Study Start

March 1, 2014

Primary Completion

October 1, 2014

Study Completion

January 1, 2015

Last Updated

July 30, 2015

Record last verified: 2014-02